Tag: Biopharmaceuticals
Firms guide Fosun Pharma’s option agreement with AriBio
HSF, Kewei and Goodwin advise Fosun Pharma on USD240 million AriBio Alzheimer’s drug agreement
Capital markets partner joins Han Kun in Hong Kong
Han Kun Law Offices has appointed Joanne Loi as a partner at its Hong Kong branch, further strengthening the firm’s capital markets practice
Pinsent Masons, China Commercial Law establish joint venture
Pinsent Masons has formed a joint venture with China Commercial Law Firm in Qianhai, Shenzhen
DaHui hires private equity partner in corporate boost
DaHui Lawyers adds PE partner Jason Song to its Shanghai team
Han Kun advises 3SBio in landmark Pfizer licensing deal
3SBio inks major licensing deal with Pfizer for cancer drug SSGJ-707
Four law firms act on ImmuneOnco IPO, HK’s first since July
Four law firms have facilitated ImmuneOnco Biopharmaceuticals’ USD40.7 million IPO on the HKEX, breaking a 50-day hiatus in listings on the Hong Kong bourse
LATEST ON LAW.ASIA
MOST READ ON LAW.ASIA
Taking TM’s measure
Trademark disputes, regulatory reforms and expansion pressures are forcing businesses to rethink brand protection
